Home › NDC Lookup › Ingredients › Vitamin A Acetate, Ascorbic Acid, Cholec... › 15370-0104-30
Quflora Pediatric VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, FOLIC ACID, CYANOCOBALAMIN, MAGNESIUM OXIDE, CUPRIC SULFATE, and SODIUM FLUORIDE 1200 [iU]/1; 60 mg; 400 [iU]/1; 15 [iU]/1; 1.2 mg; 1.3 mg; 5 mg; 1.5 mg; 108 ug Tablet, Chewable, 30-count — NDC 15370-0104-30 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Quflora Pediatric VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, FOLIC ACID, CYANOCOBALAMIN, MAGNESIUM OXIDE, CUPRIC SULFATE, and SODIUM FLUORIDE 1200 [iU]/1; 60 mg; 400 [iU]/1; 15 [iU]/1; 1.2 mg; 1.3 mg; 5 mg; 1.5 mg; 108 ug Tablet, Chewable, 30-count — NDC 15370-104-30 (Billing 15370-0104-30)

by CarWin Pharmaceutical Associates, LLC · 30 TABLET, CHEWABLE in 1 BOTTLE

This is a package of 30 tablets of Quflora Pediatric VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, FOLIC ACID, CYANOCOBALAMIN, MAGNESIUM OXIDE, CUPRIC SULFATE, and SODIUM FLUORIDE 1200 [iU]/1; 60 mg; 400 [iU]/1; 15 [iU]/1; 1.2 mg; 1.3 mg; 5 mg; 1.5 mg; 108 ug Tablet, Chewable from CarWin Pharmaceutical Associates, LLC, marketed since Jan 2014 and currently FDA-listed. It is this product's only package size.

NDC 15370-0104-30
🏷️ FDA NDC (as labeled) 15370-104-30 billing pads the product segment with a zero
Rx only On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 15370-104-30 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
15370 labeler · 104 product · 30 package
Package marketed since
Jan 6, 2014
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
30 EA per package
Barcode (UPC-A, from the NDC)
3 1537010430 3
FDA record last changed
Oct 1, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 15370-104-30
Product NDC 15370-104
11-digit billing NDC 15370010430
NCPDP billing unit EA — each (per item)
UNII 7QWA1RIO01, 68Y4CF58BV, 8ZYQ1474W7, M572600E5P, 1C6V77QF41, 25X51I8RD4 +8 more
SPL Set ID b8e08798-d8bb-4616-996b-a2c07a5d730a
Established class (EPC) Vitamin D; Vitamin B12; Vitamin C; Folate Analog
Chemical class Vitamin D; Vitamin B 12; Ascorbic Acid; Folic Acid
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-01-06
Route ORAL
Dosage form TABLET, CHEWABLE
Substance VITAMIN A ACETATE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL, DL-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; LEVOMEFOLIC ACID; FOLIC ACID; CYANOCOBALAMIN; MAGNESIUM OXIDE; CUPRIC SULFATE; SODIUM FLUORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 78441000000510
GPI class Quflora Pediatric
GCN Seq No 071902
GCN 35928
HICL code 040862
Ingredient (HICL) Pedi Multivit No.63 W-Fluoride
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C6
Therapeutic class — intermediate (HIC2) Vitamins
HIC3 code C6H
Therapeutic class — specific (HIC3) Pediatric Vitamin Preparations
AHFS code 88:28.00.00
AHFS class Multivitamin Preparations
FDB label name QUFLORA PED 0.5 MG CHEW TAB
FDB brand name Quflora
Legend status Q — Non-drug — dietary supplement, vitamin, medical food, or herbal preparation
Quick answers
  • GSN (GCN sequence number): 071902
  • GCN: 35928
  • GPI-14 (Medi-Span): 78441000000510
  • HICL (First Databank): 040862
  • AHFS class code: 88:28.00.00
Why two NDCs? The FDA registers this code as 15370-104-30 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 15370-0104-30. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name QUFLORA PED 0.5 MG CHEW TAB Ingredient Pedi Multivit No.63 W-Fluoride
🧪 What is this product?

Quflora Pediatric is a chewable tablet containing multiple vitamins and minerals. It includes vitamins A, C, D, and E, which are typically used to support general nutrition and immune function. The B vitamins (thiamine, riboflavin, niacinamide, pyridoxine, and cyanocobalamin) and folate are commonly included in pediatric formulas to support energy metabolism and growth. The product also contains magnesium, copper, and sodium fluoride. This product is marketed without an approved FDA application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
15370-0104-30 You're viewing this Main listing 30 TABLET, CHEWABLE in 1 BOTTLE 2014-01-06 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Quflora Pediatric 1200 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.2 mg/1; 1.3 mg/1; 5 mg/1; 1.5 mg/1; 108 ug 15370-0103-30 CarWin 30 tablets — — FDA listed —
Quflora Pediatric 1200 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.2 mg/1; 1.3 mg/1; 5 mg/1; 1.5 mg/1; 108 ugthis 15370-0104-30 CarWin 30 tablets — — FDA listed —
Quflora Pediatric 1200 [iU]/1; 60 mg/1; 400 [iU]/1; 15 [iU]/1; 1.2 mg/1; 1.3 mg/1; 5 mg/1; 1.5 mg/1; 108 ug 15370-0105-30 CarWin 30 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2014
On the market since
Jan 2014
📍
2026
Currently FDA-listed
12 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeRound
Imprint105
Size12 mm
ScoringNot scored
FlavorGrape
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCarWin Pharmaceutical Associates, LLC
Labeler code15370
First marketedJan 2014
Product typeHuman Prescription Drug
Portfolio17 products on file

More NDCs from CarWin Pharmaceutical Associates, LLC labeler code 15370

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⛔ Contraindications ⚠️ Warnings 🤒 Adverse Reactions 📦 How Supplied / Storage and Handling 📦 Storage and Handling 📋 Description ⚠️ Precautions 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 23 words ▾

INDICATIONS AND USAGE Quflora™ Pediatric Chewable Tablets with 0.5 mg Fluoride is a prescription dietary fluoride supplement providing twelve essential vitamins and minerals.

⏱️ Dosage and Administration 27 words ▾

DOSAGE AND ADMINISTRATION One tablet daily or as prescribed by your healthcare practitioner. Each tablet contains 0.5 mg fluoride ion (F) from 1.1 mg sodium fluoride (NaF).

⛔ Contraindications 27 words ▾

CONTRAINDICATIONS Quflora™ Pediatric Chewable Tablets with 0.5 mg Fluoride should not be used by patients with a known history of hypersensitivity to any of the listed ingredients.

⚠️ Warnings 38 words ▾

WARNINGS Keep out of the reach of children. In case of accidental overdose, seek professional emergency assistance or contact a Poison Control Center immediately. This product should be chewed and is not recommended for children under age 4.

🤒 Adverse Reactions 37 words ▾

ADVERSE REACTIONS Allergic rash and other idiosyncrasies have been rarely reported. Call your doctor for medical advice about side effects. You may report side effects or obtain product information by calling Carwin Pharmaceutical Associates, LLC at 1-844-700-5011.

📦 How Supplied / Storage and Handling 65 words ▾

HOW SUPPLIED Quflora™ Pediatric Chewable Tablets with 0.5 mg Fluoride available in child-resistant bottles of 30 (Product Code: 15370-104-30). Rx Only STORAGE Store at controlled room temperature 20° C to 25° C (68° F to 77° F), excursions permitted between 15° C and 30° C (59° F and 86° F). Protect from light, moisture and excessive heat. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.

📦 Storage and Handling 44 words ▾

STORAGE Store at controlled room temperature 20° C to 25° C (68° F to 77° F), excursions permitted between 15° C and 30° C (59° F and 86° F). Protect from light, moisture and excessive heat. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.

📋 Description 16 words ▾

DESCRIPTION Quflora™ Pediatric Chewable Tablets with 0.5 mg Fluoride is a yellow round tablet imprinted "104".

⚠️ Precautions 107 words ▾

PRECAUTIONS General The suggested dose should not be exceeded, since dental fluorosis may result from continued ingestion of large amounts of fluoride. Do not eat or drink dairy products within one hour of fluoride administration. Incompatibility of fluoride with dairy foods has been reported due to formation of calcium fluoride which is poorly absorbed.

Your healthcare practitioner can prescribe the correct dosage. Folic Acid Folic Acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

📄 Package Label / Principal Display Panel 147 words ▾

PRINCIPAL DISPLAY PANEL - 0.25 mg Tablet Bottle Label 15370-103-30 QU f LORA™ PEDIATRIC Chewable Tablets Multivitamin with 0.25 mg Fluoride Each chewable tablet contains: 0.55 mg sodium fluoride, USP Rx Only • Grape Flavor 30 Tablets carwin PHARMACEUTICAL ASSOCIATES PRINCIPAL DISPLAY PANEL - 0.25 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Bottle Label 15370-104-30 QU f LORA™ PEDIATRIC Chewable Tablets Multivitamin with 0.5 mg Fluoride Each chewable tablet contains: 1.1 mg sodium fluoride, USP Rx Only • Grape Flavor 30 Tablets carwin PHARMACEUTICAL ASSOCIATES PRINCIPAL DISPLAY PANEL - 0.5 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 1 mg Tablet Bottle Label 15370-105-30 QU f LORA™ PEDIATRIC Chewable Tablets Multivitamin with 1 mg Fluoride Each chewable tablet contains: 2.2 mg sodium fluoride, USP Rx Only • Grape Flavor 30 Tablets carwin PHARMACEUTICAL ASSOCIATES PRINCIPAL DISPLAY PANEL - 1 mg Tablet Bottle Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by CarWin Pharmaceutical Associates, LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
CarWin Pharmaceutical Associates, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 15370-0103-30 · CarWin 15370-0105-30 · CarWin →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.